Evaluation and Approach to Hematuria (Red Urine) in Children
Clinical History Assessment
Systematic approach to history taking for a child presenting with hematuria (red urine)
Physical Examination Guide
Systematic approach to examining a child with hematuria (red urine)
Diagnostic Approach
Initial Assessment
For a child presenting with hematuria (red urine), the initial assessment should include:
- Detailed history focusing on timing, associated symptoms, and color of urine
- Complete physical examination to identify associated conditions
- Basic laboratory studies to confirm true hematuria
- Assessment of vital signs and hydration status
Definitions and Classification
Understanding the presentation and classification of hematuria:
Classification | Definition | Key Features |
---|---|---|
Gross Hematuria | Visibly red, pink, or brown urine | Visible to the naked eye, often alarming to parents |
Microscopic Hematuria | >5 RBCs per high-power field on microscopic urinalysis | Detected only on urinalysis, may be isolated finding |
Isolated Hematuria | Hematuria without proteinuria or other abnormalities | Often benign, may be transient or persistent |
Hematuria with Proteinuria | Combined presence of blood and protein in urine | Suggests glomerular pathology, higher risk of renal disease |
Differential Diagnosis
System/Category | Conditions | Red Flags |
---|---|---|
Pseudo-hematuria |
- Food dyes (beets, berries) - Medications (rifampin, phenazopyridine) - Porphyria - Myoglobinuria |
- Color clears with dilution - No RBCs on microscopy - Recent ingestion of pigmented foods - Recent medication changes |
Glomerular |
- Post-infectious glomerulonephritis - IgA nephropathy - Alport syndrome - Thin basement membrane nephropathy - Lupus nephritis |
- Dysmorphic RBCs - RBC casts - Significant proteinuria - Hypertension - Edema - Recent streptococcal infection |
Non-glomerular |
- Urinary tract infection - Nephrolithiasis - Hypercalciuria - Trauma - Exercise-induced |
- Dysuria, frequency, urgency - Flank or abdominal pain - Isomorphic RBCs - History of trauma - Family history of stones |
Structural |
- Ureteropelvic junction obstruction - Polycystic kidney disease - Congenital anomalies - Nutcracker syndrome - Renal vascular malformations |
- Recurrent gross hematuria - Abdominal mass - Family history of kidney disease - Concomitant urinary tract infections - Flank pain with exercise |
Hematologic |
- Sickle cell disease/trait - Coagulopathies - Thrombocytopenia - Hemophilia - Von Willebrand disease |
- Family history of bleeding disorders - Concurrent bruising - Prolonged bleeding after minor trauma - African or Mediterranean descent |
Malignancy |
- Wilms' tumor - Rhabdomyosarcoma - Renal cell carcinoma - Transitional cell carcinoma - Leukemia |
- Palpable abdominal mass - Painless gross hematuria - Weight loss - Pallor, fatigue - Persistent or recurrent hematuria |
Laboratory Studies
Initial evaluation for a child with hematuria:
Investigation | Clinical Utility | When to Consider |
---|---|---|
Urinalysis | Confirm hematuria, assess for proteinuria, pyuria, casts | All patients with suspected hematuria |
Urine Culture | Identify urinary tract infection | Presence of pyuria, nitrites, leukocyte esterase, or symptoms of UTI |
Complete Blood Count | Assess for anemia, thrombocytopenia, leukocytosis | All patients with gross hematuria or persistent microscopic hematuria |
Renal Function Tests (BUN, Creatinine) | Evaluate kidney function | All patients with persistent hematuria or signs of renal disease |
Coagulation Studies (PT, PTT) | Screen for bleeding disorders | Family history of bleeding disorders, persistent hematuria |
Serum Complement (C3, C4) | Assess for post-infectious or complementopathies | Suspected glomerulonephritis, family history of nephritis |
Urine Calcium/Creatinine Ratio | Evaluate for hypercalciuria | Suspected nephrolithiasis, family history of stones |
ASO Titer, Throat Culture | Identify recent streptococcal infection | Suspected post-streptococcal glomerulonephritis |
Advanced Studies
Consider these studies based on initial findings:
Investigation | Clinical Utility | When to Consider |
---|---|---|
Renal Ultrasound | Evaluate kidney structure, detect stones, masses, or anomalies | Persistent hematuria, family history of renal disease, abdominal/flank pain |
Voiding Cystourethrogram (VCUG) | Evaluate for vesicoureteral reflux, posterior urethral valves | Recurrent UTIs, suspicion of structural abnormality |
CT Scan with Contrast | Detailed imaging of renal structures and vascular anomalies | Suspected tumor, vascular malformation, or trauma |
24-hour Urine Collection | Quantify protein, calcium, oxalate, citrate, and other solutes | Suspected nephrolithiasis, persistent proteinuria, recurrent hematuria |
Renal Biopsy | Definitive diagnosis of glomerular disease | Persistent hematuria with proteinuria, decreased GFR, or suspected glomerulonephritis |
Cystoscopy | Direct visualization of bladder and urethra | Persistent unexplained gross hematuria, suspected structural abnormality |
Autoimmune Panels (ANA, Anti-dsDNA) | Screen for lupus and other autoimmune nephritides | Systemic symptoms, female adolescent, family history of autoimmune disease |
Diagnostic Algorithm
A stepwise approach to evaluating hematuria in children:
- Confirm true hematuria with urinalysis, distinguish from pseudohematuria
- Determine glomerular vs. non-glomerular source based on RBC morphology, presence of casts
- Evaluate for associated proteinuria - increases likelihood of significant renal disease
- Screen for UTI with urine culture if pyuria present
- Assess renal function with BUN, creatinine
- Evaluate for hypercalciuria with spot calcium/creatinine ratio
- Consider renal ultrasound for persistent or recurrent hematuria
- Further testing based on clinical suspicion (complement levels, coagulation studies)
- Nephrology referral for persistent hematuria with proteinuria, hypertension, or abnormal renal function
- Consider renal biopsy if progressive disease or diagnosis unclear despite non-invasive workup
Management Strategies
General Approach to Management
Key principles in managing pediatric hematuria:
- Stratify risk: Distinguish between benign causes and those requiring intervention
- Treat underlying causes: Target specific diagnosis when identified
- Monitor appropriately: Follow-up based on severity and etiology
- Parental education: Explain significance, reassure when appropriate, and outline monitoring plan
- Nephrology referral: For complex cases, persistent or concerning presentations
Management by Etiology
Etiology | Management Approach | Follow-up Recommendations |
---|---|---|
Isolated Microscopic Hematuria |
- Reassurance if transient - Routine urinalysis monitoring - Avoidance of excessive contact sports if persistent - Monitoring of blood pressure |
- Repeat urinalysis in 2-4 weeks - If persistent >6 months, consider nephrology referral - Annual BP monitoring - Check siblings if familial history |
Urinary Tract Infection |
- Appropriate antibiotic therapy - Adequate hydration - Evaluation for anatomic abnormalities if recurrent - Culture-directed therapy |
- Follow-up urinalysis after completion of antibiotics - Imaging if recurrent or febrile UTI - Consider prophylaxis if structural abnormality - Education on prevention strategies |
Post-infectious Glomerulonephritis |
- Treat underlying infection if still present - Sodium restriction if edema present - Blood pressure control if hypertensive - Monitor renal function |
- Weekly urinalysis until clear - Monitor BP until normalized - Follow complement levels until normalized - Long-term monitoring of renal function |
Hypercalciuria |
- Increased fluid intake - Dietary sodium restriction - Consider thiazide diuretics if symptomatic - Potassium citrate if hypocitruria present |
- Follow-up calcium/creatinine ratio - Periodic ultrasound if history of stones - Annual metabolic evaluation - Family screening if genetic predisposition |
IgA Nephropathy |
- ACE inhibitors for proteinuria/hypertension - Immunosuppression for progressive disease - Omega-3 fatty acids may be beneficial - Tonsillectomy in selected cases |
- Regular monitoring of proteinuria - Frequent BP checks - Renal function tests every 3-6 months - Long-term nephrology follow-up |
Alport Syndrome |
- ACE inhibitors to reduce proteinuria - Hearing and vision evaluations - Genetic counseling - Consider clinical trials |
- Multidisciplinary approach (nephrology, ENT, ophthalmology) - Regular monitoring of renal function - Family screening - Preparation for potential transplantation |
Nephrolithiasis |
- Pain management - Hydration - Dietary modifications based on stone type - Urological intervention if obstruction |
- Strain urine to collect stones for analysis - Follow-up imaging to ensure stone passage - Metabolic evaluation - Prevention strategies based on stone composition |
Exercise-induced Hematuria |
- Temporary reduction in exercise intensity - Adequate hydration - Exclusion of other causes |
- Post-exercise urinalysis - Resolution expected within 24-48 hours - Consider other diagnoses if persistent - No long-term restrictions if isolated |
Pharmacological Management
Medication Class | Indications | Considerations in Children |
---|---|---|
Antibiotics |
- Urinary tract infections - Streptococcal infections |
- Selection based on local resistance patterns - Age-appropriate dosing - Consider compliance issues - Monitor for adverse effects |
ACE Inhibitors |
- Proteinuric renal diseases - Hypertension with renal involvement |
- Start at low doses - Monitor potassium and renal function - Contraindicated in pregnancy (adolescents) - Watch for cough as side effect |
Thiazide Diuretics |
- Hypercalciuria - Prevention of calcium stones |
- Monitor electrolytes - Start with low doses - Consider potassium supplementation - Evaluate for hypotension |
Potassium Citrate |
- Hypocitruria - Uric acid stones |
- Palatability issues in children - Multiple daily dosing may affect compliance - Monitor serum potassium - Available in multiple formulations |
Immunosuppressants |
- Lupus nephritis - Rapidly progressive glomerulonephritis - Severe IgA nephropathy |
- Reserved for severe disease - Increased infection risk - Growth and development concerns - Specialist management required |
Corticosteroids |
- Immune-mediated nephritis - Minimal change disease with hematuria |
- Growth suppression with prolonged use - Monitor for cushingoid features - Bone density concerns - Consider steroid-sparing agents for chronic use |
Procedural/Surgical Interventions
Procedure | Indications | Considerations |
---|---|---|
Renal Biopsy |
- Persistent hematuria with proteinuria - Abnormal renal function - Suspected glomerulonephritis - Family history of progressive renal disease |
- Usually performed percutaneously under ultrasound guidance - Requires monitoring for post-procedure bleeding - Consider sedation or anesthesia requirements - Risk-benefit assessment critical |
Lithotripsy |
- Symptomatic renal stones - Stones unlikely to pass spontaneously - Obstructing stones |
- Size and location dependent - Less invasive than surgical approaches - Age and size limitations - Post-procedure stenting may be required |
Ureteroscopy |
- Stone removal - Evaluation of upper tract hematuria source - Management of ureteral strictures |
- Technical challenges in very young children - May require specialized pediatric instruments - Risk of ureteral injury - Stent placement often necessary |
Cystoscopy |
- Evaluation of bladder pathology - Recurrent unexplained gross hematuria - Suspected lower urinary tract anomaly |
- Less invasive than upper tract procedures - Can be diagnostic and therapeutic - Anesthesia requirements - Limited utility for upper tract pathology |
Parent and Patient Education
- Understanding hematuria: Explain difference between benign and concerning causes
- Monitoring: Instruct on home urine monitoring if appropriate
- Diet and hydration: Emphasize adequate fluid intake (1-2L/day based on age and weight)
- Activity modifications: Guidance on sports participation with specific conditions
- Red flags: When to seek immediate medical attention
- Genetic counseling: For familial conditions like Alport syndrome
- Long-term outlook: Prognosis and expectations for specific diagnosis
When to Refer
- Nephrology:
- Persistent hematuria (>6 months)
- Hematuria with proteinuria
- Hematuria with hypertension
- Abnormal renal function
- Family history of hereditary nephritis
- Urology:
- Recurrent gross hematuria without glomerular cause
- Suspected anatomic abnormality
- Symptomatic nephrolithiasis
- Trauma with hematuria
- Hematology:
- Suspected coagulation disorder
- Thrombocytopenia with hematuria
- Sickle cell disease with hematuria
- Rheumatology:
- Hematuria with systemic autoimmune symptoms
- Suspected lupus nephritis
- Vasculitis with renal involvement
- Emergency Referral:
- Gross hematuria with clots and pain
- Hematuria with acute kidney injury
- Significant trauma with hematuria
- Hematuria with severe hypertension
Follow-up and Monitoring
Condition | Monitoring Parameters | Frequency |
---|---|---|
Isolated Microscopic Hematuria |
- Urinalysis - Blood pressure - Urine protein/creatinine ratio |
- Initially at 2-4 weeks - If persistent, every 3-6 months - Annual thereafter if stable |
Post-infectious Glomerulonephritis |
- Urinalysis - Blood pressure - Renal function - Complement levels |
- Weekly until improving - Monthly until resolved - Every 3-6 months for 1-2 years |
IgA Nephropathy |
- Urinalysis - Urine protein/creatinine ratio - Blood pressure - Renal function |
- Every 3 months initially - Every 6 months if stable - Lifelong monitoring |
Hypercalciuria |
- Urine calcium/creatinine ratio - Urinalysis - Renal ultrasound if history of stones |
- Every 3-6 months initially - Annually if stable - More frequent during growth spurts |
Alport Syndrome |
- Urinalysis - Proteinuria quantification - Renal function - Hearing assessment - Ophthalmologic examination |
- Nephrology: every 3-6 months - Audiology: annually - Ophthalmology: annually - More frequent with disease progression |